Clinical Trial Update: Study Of Weight-Based Versus Standard Dose Enoxaparin Thromboprophylaxis In High-Risk Hospitalized Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial comparing weight-based vs standard-dose enoxaparin for venous thromboembolism prevention in high-risk hospitalized cancer patients has completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Venous Thromboembolism

Drugs mentioned

• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Venous Thormboembolism | Phase 2 | Status: COMPLETED | Results posted: 2021-06-10